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Background:  Recent reports suggest that eicosapentaenoic acid to arachidonic acid ratio (EPA/AA ratio) is a new risk marker for coronary artery 
disease. The aim of this study was to evaluate the relationship between EPA/AA ratio and coronary plaque vulnerability in non-hypercolesterolemia 
patients.
methods:  Consecutive non-hypercolesterolemia patients with stable angina pectoris (n = 76) without any lipid lowering therapies were divided 
into two groups based on the presence of in vivo thin cap fibroatheroma (TCFA) in de novo target vessels assessed by virtual histology intravascular 
ultrasound (VH-IVUS): VH- TCFA(+) group; n=18 or VH-TCFA(-) group; n=58.
results:  Total cholesterol, low-density lipoprotein cholesterol, high-density cholesterol, and triglyceride levels were similar between the two groups. 
On the other hand, EPA/AA ration was significantly lower in Patients with in vivo TCFA than patients without in vivo TCFA (0.39±0.18 vs 0.51±0.23, 
p < 0.05). In addition, docosahexaenoic acid level was also significantly lower in patients with in vivo TCFA (117.4±29.5 vs 140.4±35.4, p<0.05). 
Percent necrotice core volume was significantly higher in TCFA group (25.3±5.2% vs 19.6±4.3%, p<0.01).
conclusions:  Low EPA/AA ration and low docosahexaenoic acid level might be associated with coronary plaque vulnerability even in patient with 
non-hypercolesterolemia.
Laboratory results
VH-TCFA(+) VH-TCFA (-) p
EPA/AA 0.39±0.18 0.51±0.23 <0.05
DHA, μg/ml 117.4±29.5 140.4±35.4 0.01
CRP, mg/dl 0.31±0.61 0.20±0.83 0.6
